Berberine combined with stachyose protects against obesity by modulating gut microbiota and increasing leptin sensitivity
Science China Life Sciences · 2026
DOI: 10.1007/s11427-024-2943-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science China Life Sciences, 2026. Verfasst von Dan Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, an…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Berberine, Obesity, Leptin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Leptin resistance is a hallmark of obesity. Recent evidence shows that gut microbiota is associated with the development and progression of leptin resistance. However, whether intervention targeting gut microbiota can improve leptin sensitivity remains to be fully established. In the current investigation, we have demonstrated that co-administration of berberine, an isoquinoline alkaloid compound, and stachyose, a prebiotic, could enhance leptin sensitivity and reduce body weight in diet-induced obesity (DIO) mice, via an effect associated with gut microbiota modulation. Notably, the combination of berberine and stachyose significantly increased the abundance of Blautia producta, altered host purine metabolism, and elevated serum and hypothalamic levels of a purine metabolite, inosine. Furthermore, direct supplementation with inosine further ameliorated inflammation and endoplasmic reticulum stress in the hypothalamus and improved leptin sensitivity in obese mice. These findings suggest that berberine combined with stachyose represents a novel leptin sensitizer for obesity, acting through the modulation of gut microbiota and subsequently alteration in host purine metabolism, particularly with the involvement of inosine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, and Department of Metabolism and Endocrinology, the Second Xiangya Hospi…
- State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Institute of Microbiol…
- Key Laboratory of Biometallurgy, Ministry of Education, School of Minerals Processing and Bioengineering, Central South University, Changsha, 410081, China.
- State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, 100101, China.
- School of Life and Health Sciences, Fuyao University of Science and Technology, Fuzhou, 350109, China. xielw@gdim.cn.
- Fuyang Institute of Zhejiang Chinese Medical University, Hangzhou, 310000, China. xielw@gdim.cn.
Zitieren
APA
Wu, D., Zhang, F., Wang, H., Xie, L., Liu, B., Xiao, S., Chen, W., Ye, Y., Chen, Z., Shui, G., Zeng, W., Xie, L., & Hu, F. (2026). Berberine combined with stachyose protects against obesity by modulating gut microbiota and increasing leptin sensitivity. Science China Life Sciences. https://doi.org/10.1007/s11427-024-2943-4
Vancouver
Wu D, Zhang F, Wang H, Xie L, Liu B, Xiao S, et al. Berberine combined with stachyose protects against obesity by modulating gut microbiota and increasing leptin sensitivity. Science China Life Sciences. 2026. doi:10.1007/s11427-024-2943-4
BibTeX
@article{Wu2026,
author = {Wu, Dan and Zhang, Feng and Wang, Huiying and Xie, Lijun and Liu, Bingdong and Xiao, Shanshan and Chen, Wei and Ye, Yuqing and Chen, Zhinan and Shui, Guanghou and Zeng, Weimin and Xie, Liwei and Hu, Fang},
title = {Berberine combined with stachyose protects against obesity by modulating gut microbiota and increasing leptin sensitivity},
journal = {Science China Life Sciences},
year = {2026},
doi = {10.1007/s11427-024-2943-4}
}
EUVIMED